Pivot Technology Solutions gets target raise at Echelon after Intel sale

Echelon Wealth Partners analyst Gianluca Tucci likes the new deal between IT solutions company Pivot Technology Solutions (Pivot Technology Solutions Stock Quote, Chart, News TSX:PTG) and US chip-maker Intel (Intel Stock Quote, Chart, News NASDAQ:INTC).

The analyst says the sale of Pivot’s Smart Edge software business to Intel crystallizes value creation for Pivot.

In an update to clients on Tuesday, Tucci maintained his “Buy” rating with the raised target price of C$3.30 per share (previously C$2.75 per share).

Toronto-based IT infrastructure company Pivot announced on Tuesday the $27-million deal which will see Pivot’s edge computing software business go to Intel along with 25 employees joining Intel’s Network and Custom Logic Group as well as a three-year preferred channel partner agreement between the two companies which designates Pivot as a non-exclusive preferred systems integrator and channel partner for Smart Edge-based solutions. The deal is expected to close in coming weeks. (All figures in US dollars unless where noted otherwise.)

Intel plans to make a push into equipment for 5G networks and sees the development of its edge computing prowess to be part of that strategy.

“Intel is the right company and brand to advance and scale Smart Edge’s software solution. Our partnership with Intel will leverage Pivot’s core strengths as a technology integrator and service provider with Intel’s advanced technology solutions to drive the adoption of the Smart Edge platform,” said Pivot CEO Kevin Shank in a press release.

Tucci says that the partnership works well for Pivot, which while loading onto Intel the cost of further developing the Smart Edge software, can still resell the software along with design, integrate, support and manage the software solutions, all of which are Pivot’s core competencies, the analyst says.

“We believe the sale and partnership announcement is value-creative and allows for flexibility in strategic alternatives for the use of proceeds, which we believe can include a combination of debt reduction, common dividend increase, special dividend, and/or a niche services acquisition,” writes Tucci.

“For strictly contextual purposes, the $5.1-million net-spend in 2018 on Smart-Edge is more than enough to double 2018’s common dividend spend of $4.8 million. We look for a material one-time EPS gain in Q419 results with an acceleration in services growth as a result of the preferred partnership in 2020 and beyond. We leave our revenue estimates unchanged for now with a slight reduction in SG&A as a result of the lessened expenses and look to fine-tune our 2020+ estimates and valuation after its Q319 earnings call in November,” he writes.

Tucci notes that while it’s obvious that revenue from Pivot’s major customers has been on the decline since the third quarter of 2018, where majors in Q2 of this year represented 23.0 per cent of revenue as compared to 38.0 per cent a year earlier, the company hasn’t lost these majors as customers, while the company has also said that its services pipeline has been growing over the past several quarters. The analyst says that the Intel deal should help with higher margin revenue growth in 2020 and beyond for Pivot.

Tucci is calling for fiscal 2019 revenue and adjusted EBITDA of $1.27 billion and $26 million, respectively, and 2020 revenue and adjusted EBITDA of $1.31 billion and $32 million, respectively.

His C$3.30 target represented a projected 12-month return of 142 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

2 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

2 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

3 days ago

Rogers is an undervalued stock, RBC says

With the integration of Shaw Communications underway, RBC analyst Drew McReynolds says Rogers Communications (Rogers Communications Stock Quote, Chart, News,… [Read More]

4 days ago

Tornado Global Hydrovacs is still a double, Beacon says

Following fourth quarter results he describes as "stronger than expected", Beacon Securities analyst Russell Stanley has raised his price target… [Read More]

4 days ago

Sell your Molson Coors stock, Citi says

Ahead if its first quarter results, Citi analyst Filippo Falorni says there is not much to like about Molson Coors… [Read More]

5 days ago